所有图片(1)
About This Item
经验公式（希尔记法）:
C8H15NO4
CAS号:
分子量:
189.21
MDL號碼:
分類程式碼代碼:
12352209
PubChem物質ID:
NACRES:
NA.22
推荐产品
品質等級
化驗
≥98% (TLC)
形狀
crystals
光學活性
[α]/D +4.0±0.3°, c = 1 in H2O
反應適用性
reaction type: solution phase peptide synthesis
應用
peptide synthesis
SMILES 字串
N[C@@H](CCCC1OCCO1)C(O)=O
InChI
1S/C8H15NO4/c9-6(8(10)11)2-1-3-7-12-4-5-13-7/h6-7H,1-5,9H2,(H,10,11)/t6-/m0/s1
InChI 密鑰
RQULWPSGQYZREI-LURJTMIESA-N
包裝
Bottomless glass bottle. Contents are inside inserted fused cone.
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
Michael F Wempe et al.
Journal of inherited metabolic disease, 42(3), 565-574 (2019-01-22)
Pyridoxine-dependent epilepsy (PDE) is often characterized as an early onset epileptic encephalopathy with dramatic clinical improvement following pyridoxine supplementation. Unfortunately, not all patients present with classic neonatal seizures or respond to an initial pyridoxine trial, which can result in the
Elizabeth Mary Mathew et al.
International journal of analytical chemistry, 2018, 2583215-2583215 (2018-08-30)
Pyridoxine dependent epilepsy is a condition where the affected infant or child has prolonged seizures (status epilepticus), which are nonresponsive to anticonvulsant therapy but can be treated with pharmacological doses of pyridoxine. If identified earlier and treated prophylactically with pyridoxine
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门